Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells

Biochemical Journal

Volumn 434, Issue 3, 2011, Pages 473-482

  Patel, Nitin ^a   Tahara, Stanley M ^a   Malik, Punam ^b   Kalra, Vijay K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

3 untranslated region (3 UTR); Adenosine and uridine rich element (ARE); MicroRNA (miRNA); Placental growth factor (PlGF); Plasminogen activator inhibitor 1 (PAI 1); Sickle cell anaemia (SCA)

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 301A; MICRORNA 30C; OLIGONUCLEOTIDE; PLACENTAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BLOOD SAMPLING; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FIBRINOLYSIS; GENE CONSTRUCT; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG ENDOTHELIUM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE; RNA STABILITY; SICKLE CELL ANEMIA; TRANSCRIPTION REGULATION; UPREGULATION;

3' UNTRANSLATED REGIONS; ANEMIA, SICKLE CELL; CELLS, CULTURED; CHILD; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; LUNG; MICRORNAS; MICROVESSELS; OLIGONUCLEOTIDES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY PROTEINS; RNA, MESSENGER;

EID: 79952155291     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101585     Document Type: Article

References (50)

1. Eddy, A. A. (2002) Plasminogen activator inhibitor-1 and the kidney. Am. J. Physiol. Renal Physiol. 283, F209-F220
2. Fay, W. P. (2004) Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury. Trends Cardiovasc. Med. 14, 196-202
3. Ataga, K. I. and Key, N.S. (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am. Soc. Hematol. Educ. Program 91-96
4. Ataga, K. I., Moore, C. G., Hillery, C. A., Jones, S., Whinna, H. C., Stayhorn, D., Sohier, C., Hinderliter, A., Praise, L. V. and Orringer, E.P. (2008) Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Haematologica 93, 20-26 (Pubitemid 351156147)
5. Nsiri, B., Gritli, N., Mazigh, C., Ghazouani, E., Fattoum, S. and Machghoul, S. (1997) Fibrinolytic response to venous occlusion in patients with homozygous sickle cell disease. Hematol. Cell Ther. 39, 229-232
6. Hillery, C. A. and Panepinto, J. A. (2004) Pathophysiology of stroke in sickle cell disease. Microcirculation 11, 195-208
7. Dupont, D. M., Madsen, J. B., Kristensen, T., Bodker, J. S., Blouse, G. E., Wind, T. and Andreasen, P. A. (2009) Biochemical properties of plasminogen activator inhibitor-1. Front. Biosci. 14, 1337-1361
8. Fink, T., Kazlauskas, A., Poellinger, L., Ebbesen, P. and Zachar, V. (2002) Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood 99, 2077-2083 (Pubitemid 34525491)
9. Patel, N., Sundaram, N., Yang, M., Madigan, C., Kalra, V. K. and Malik, P. (2010) Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 in sickle cell disease (SCD). J. Biol. Chem. 285, 16713-16722
10. Liao, H., Hyman, M. C., Lawrence, D. A. and Pinsky, D. J. (2007) Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1α, and C/EBPα. FASEB J. 21, 935-949 (Pubitemid 46348266)
11. Kietzmann, T., Samoylenko, A., Roth, U. and Jungermann, K. (2003) Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes. Blood 101, 907-914 (Pubitemid 36139358)
12. Keeton, M. R., Curriden, S. A., van Zonneveld, A. J. and Loskutoff, D. J. (1991) Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem. 266, 23048-23052 (Pubitemid 21908758)
13. Vulin, A. I. and Stanley, F. M. (2004) Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J. Biol. Chem. 279, 25172-25178
14. Doench, J. G. and Sharp, P. A. (2004) Specificity of microRNA target selection in translational repression. Genes Dev. 18, 504-511
15. Rajewsky, N. (2006) microRNA target predictions in animals. Nat. Genet. 38, S8-S13
16. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
17. Martin, M. M., Lee, E. J., Buckenberger, J. A., Schmittgen, T. D. and Elton, T. S. (2006) MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem. 281, 18277-18284
18. Ambros, V. (2004) The function of animal microRNAs. Nature 431, 350-355
19. Taganov, K. D., Boldin, M. P., Chang, K. J. and Baltimore, D. (2006) NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103, 12481-12486
20. Bi, Y., Liu, G. and Yang, R. (2009) MicroRNAs: novel regulators during the immune response. J. Cell Physiol. 218, 467-472
21. Baltimore, D., Boldin, M. P., O'Connell, R. M., Rao, D. S. and Taganov, K. D. (2008) MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9, 839-845
22. Davidson-Moncada, J., Papavasiliou, F.N. and Tam, W. (2010) MicroRNAs of the immune system: roles in inflammation and cancer. Ann. N.Y. Acad. Sci. 1183, 183-194
23. Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J. J. and Natarajan, R. (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. U.S.A. 104, 3432-3437
24. Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I., Rossi, J. J. and Natarajan, R. (2009) TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 11, 881-889
25. Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., Alder, H., Agosto-Perez, F. J., Davuluri, R., Liu, C. G., Croce, C. M., Negrini, M., Calin, G. A. and Ivan, M. (2007) A microRNA signature of hypoxia. Mol. Cell. Biol. 27, 1859-1867
26. Schickel, R., Boyerinas, B., Park, S. M. and Peter, M. E. (2008) MicroRNAs: key players in the innate immune system, differentiation, tumorigenesis and cell death. Oncogene 27, 5959-5974
27. Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y. and Ochiya, T. (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442-17452
28. Gonsalves, C. S. and Kalra, V. K. (2010) Hypoxia-mediated expression of 5-lipoxygenase-activating protein involves HIF-1α and NF-κB and microRNAs 135a and 199a-5p. J. Immunol. 184, 3878-3888
29. Patel, N., Gonsalves, C. S., Yang, M., Malik, P. and Kalra, V. K. (2009) Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease. Blood 113, 1129-1138
30. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic. Acids Res. 29, e45
31. Kang, J., Ramu, S., Lee, S., Aguilar, B., Ganesan, S. K., Yoo, J., Kalra, V. K., Koh, C. J. and Hong, Y. K. (2009) Phosphate-buffered saline-based nucleofection of primary endothelial cells. Anal. Biochem. 386, 251-255
32. Patel, N. and Kalra, V. K. (2010) Placenta growth factor (PlGF)-induced early growth response 1 (Egr-1) regulateshypoxia-inducible factor-1a in endothelial cells. J. Biol. Chem. 285, 20570-20579
33. Seggerson, K., Tang, L. and Moss, E. G. (2002) Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev. Biol. 243, 215-225
34. Long, J., Wang, Y., Wang, W., Chang, B. H. J. and Danesh, F. R. (2010) Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J. Biol. Chem. 285, 23457-23465
35. El Gazzar, M. and McCall, C. E. (2010) MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J. Biol. Chem. 285, 20940-20951
36. Hauser, S. and Weich, H. A. (1993) A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9, 259-268
37. Tordjman, R., Delaire, S., Plouet, J., Ting, S., Gaulard, P., Fichelson, S., Romeo, P. H. and Lemarchandel, V. (2001) Erythroblasts are a source of angiogenic factors. Blood 97, 1968-1974 (Pubitemid 32239075)
38. Selvaraj, S. K., Giri, R. K., Perelman, N., Johnson, C., Malik, P. and Kalra, V. K. (2003) Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 102, 1515-1524
39. Patel, N., Gonsalves, C. S., Malik, P. and Kalra, V. K. (2008) Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1α. Blood 112, 856-865
40. Sundaram, N., Tailor, A., Mendelsohn, L., Wansapura, J., Wang, X., Higashimoto, T., Pauciulo, M. W., Gottliebson, W., Kalra, V. K., Nichols, W. C. et al. (2010) High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension. Blood 116, 109-112
41. Montouri, N., Rossi, G. and Ragno, P. (2002) Post-transcriptional regulation of gene expression in the plasminogen activation system. Biol. Chem. 383, 47-53
42. Tillmann-Bogush, M., Heaton, J. and Gelehrter, T. (1999) Cyclic nucleotide regulation of PAI-1 mRNA stability. Identification of cytosolic proteins that interact with an a-rich sequence. J. Biol. Chem. 274, 1172-1179
43. Doller, A., Gauer, S., Sobkowiak, E., Geiger, H., Pfeilschifter, J. and Eberhardt, W. (2009) Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen R. Am. J. Pathol. 174, 1252-1263
44. Shanmugam, N., Reddy, M. A. and Natarajan, R. (2008) Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products. J. Biol. Chem. 283, 36221-36233
45. Fort, A., Borcel, C., Migliavacca, E., Antonarakis, S. E., Fish, R. J. and Neerman-Arbez, M. (2010) Regulation of fibrinogen production by microRNAs. Blood 116, 2608-2615
46. Kapinas, K., Kessler, C., Ricks, T., Gronowicz, G. and Delany, A. M. (2010) miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J. Biol. Chem. 285, 25221-25231
47. Cao, G., Huang, B., Liu, Z., Zhang, J., Xu, H., Xia, W., Li, J., Li, S., Chen, L., Ding, H. et al. (2010) Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/CREB pathways. Biochem. Biophys. Res. Commun. 396, 978-982
48. Nakshatri, H., Bhat-Nakshatri, P. and Currie, R.A. (1996) Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J. Biol. Chem. 271, 28784-28791
49. Murai-Takeda, A., Shibata, H., Kurihara, I., Kobayashi, S., Yokota, K., Suda, N., Mitsuishi, Y., Jo, R., Kitagawa, H., Kato, S. et al. (2010) NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor. J. Biol. Chem. 285, 8084-8093
50. Kim, D. H. and Rossi, J. J. (2007) Strategies for silencing human disease using RNA interference. Nat. Genet. 8, 173-184